• OncologyTube
    • 0
      • Title
        User LIVE NOW
      • LIVE NOW
        Title
        User
        • Sign In
    • Home
    • Trending

    • Sign In

    • Audios and Videos
    • Videos
    • Audios

    • Channels

    • Browse Channels

    • Categories

    • Acute Lymphoblastic Leukemia 5637
    • Acute Myelogenous Leukemia 149
    • Bladder Cancer 49
    • Bone Metastases 1
    • Brain Cancer 16
    • Breast Cancer 121
    • Business Management 2
    • Cervical Cancer 2
    • Chronic Lymphocytic Leukemia 156
    • Chronic Myelogenous Leukemia 21
    • Colorectal Cancer 75
    • Gastrointestinal Cancer 70
    • General 246
    • Head and Neck Cancers 34
    • Hematologic Malignancies 79
    • Hodgkin Lymphoma 18
    • Immunotherapy 88
    • Kidney Cancer 364
    • Liver Cancer 11
    • Lymphoma 145
    • Melanoma and Skin Cancer 51
    • Multiple Myeloma 338
    • Myeloproliferative Disease 15
    • News 115
    • Non-Hodgkin Lymphoma 45
    • Non-Small Cell Lung Cancer 267
    • Other 110
    • Ovarian Cancer 10
    • Pancreatic Cancer 54
    • Patient Resources 27
    • Prostate Cancer 148
    • Small Cell Lung Cancer 58
    • Soft Tissue Sarcoma 9
    • Supportive Care 38
    • Testicular Cancer 2
    • Urology 6
    • Uterine Cancer 2

    • About
    • Contact
    Pharma

    PharmaMar

    My videos
    Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin
    0:04:01

    Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin

    Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new drug.

    Small Cell Lung Cancer
    61 Views
    3 months ago
    PharmaMar
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved
    0:02:13

    Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved

    Small Cell Lung Cancer
    39 Views
    3 months ago
    PharmaMar
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin
    0:07:54

    Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin

    Small Cell Lung Cancer
    46 Views
    3 months ago
    PharmaMar
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
    00:29:12

    Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

    Small Cell Lung Cancer
    425 Views
    6 months ago
    PharmaMar
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
    00:28:53

    Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

    Small Cell Lung Cancer
    866 Views
    6 months ago
    PharmaMar
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm
    00:00:28

    Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm

    Small Cell Lung Cancer
    577 Views
    6 months ago
    PharmaMar
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

      Copyright 2019 Medicus Networks, Inc.